WO1996025956B1 - Conjugue pour le dosage individuel de medicaments - Google Patents

Conjugue pour le dosage individuel de medicaments

Info

Publication number
WO1996025956B1
WO1996025956B1 PCT/DE1996/000267 DE9600267W WO9625956B1 WO 1996025956 B1 WO1996025956 B1 WO 1996025956B1 DE 9600267 W DE9600267 W DE 9600267W WO 9625956 B1 WO9625956 B1 WO 9625956B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
conjugate according
metal
conjugate
derivative
Prior art date
Application number
PCT/DE1996/000267
Other languages
German (de)
English (en)
Other versions
WO1996025956A3 (fr
WO1996025956A2 (fr
Filing date
Publication date
Priority claimed from DE19505960A external-priority patent/DE19505960A1/de
Application filed filed Critical
Priority to US08/913,217 priority Critical patent/US6410695B1/en
Priority to DK96903881T priority patent/DK0810883T3/da
Priority to JP8525299A priority patent/JPH11500134A/ja
Priority to EP96903881A priority patent/EP0810883B1/fr
Priority to AT96903881T priority patent/ATE221391T1/de
Priority to DE59609508T priority patent/DE59609508D1/de
Publication of WO1996025956A2 publication Critical patent/WO1996025956A2/fr
Publication of WO1996025956A3 publication Critical patent/WO1996025956A3/fr
Publication of WO1996025956B1 publication Critical patent/WO1996025956B1/fr

Links

Abstract

L'invention concerne un conjugué contenant un principe actif et un composé présentant un site de liaison pour des composés métalliques. L'invention concerne en outre un procédé de fabrication de ce conjugué et son utilisation.
PCT/DE1996/000267 1995-02-21 1996-02-21 Conjugue pour le dosage individuel de medicaments WO1996025956A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US08/913,217 US6410695B1 (en) 1995-02-21 1996-02-21 Individual medicament dosing conjugate
DK96903881T DK0810883T3 (da) 1995-02-21 1996-02-21 Konjugat indeholdende DTPA og albumin til individuel dosering af lægemidler
JP8525299A JPH11500134A (ja) 1995-02-21 1996-02-21 個体に投与する薬学製剤のためのコンジュゲート
EP96903881A EP0810883B1 (fr) 1995-02-21 1996-02-21 Conjugue contenant dtpa et albumine pour le dosage individuel de medicaments
AT96903881T ATE221391T1 (de) 1995-02-21 1996-02-21 Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
DE59609508T DE59609508D1 (de) 1995-02-21 1996-02-21 Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19505960A DE19505960A1 (de) 1995-02-21 1995-02-21 Konjugat zur individuellen Dosierung von Arzneimitteln
DE19505960.3 1995-02-21

Publications (3)

Publication Number Publication Date
WO1996025956A2 WO1996025956A2 (fr) 1996-08-29
WO1996025956A3 WO1996025956A3 (fr) 1996-12-27
WO1996025956B1 true WO1996025956B1 (fr) 1997-02-13

Family

ID=7754621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/000267 WO1996025956A2 (fr) 1995-02-21 1996-02-21 Conjugue pour le dosage individuel de medicaments

Country Status (8)

Country Link
US (1) US6410695B1 (fr)
EP (1) EP0810883B1 (fr)
JP (1) JPH11500134A (fr)
AT (1) ATE221391T1 (fr)
DE (2) DE19505960A1 (fr)
DK (1) DK0810883T3 (fr)
ES (1) ES2180737T3 (fr)
WO (1) WO1996025956A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1042003A1 (fr) * 1998-03-23 2000-10-11 Conjuchem, Inc. Apport local d'agents therapeutiques a action prolongee
US6740756B1 (en) 1998-07-07 2004-05-25 Smithkline Beecham Corporation Fluorescent lanthanide chelates
JP2002519404A (ja) * 1998-07-07 2002-07-02 スミスクライン・ビーチャム・コーポレイション 新規蛍光ランタニドキレート
DE19847362A1 (de) * 1998-10-14 2000-04-20 Deutsches Krebsforsch Makromolekulare Wirkstoffkonjugate und Verfahren zu ihrer Herstellung
AUPP856399A0 (en) * 1999-02-08 1999-03-04 Australian Membrane And Biotechnology Research Institute Improved compounds for protein binding
GB9929801D0 (en) * 1999-12-16 2000-02-09 Btg Int Ltd Anti-cancer agents iii
JP2008513533A (ja) * 2004-09-23 2008-05-01 ゲルベ Ｃｅｓｔイメージング用の造影剤封入システム
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
US8926945B2 (en) * 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
FR2980364B1 (fr) 2011-09-26 2018-08-31 Guerbet Nanoemulsions et leur utilisation comme agents de contraste
FR3001154B1 (fr) 2013-01-23 2015-06-26 Guerbet Sa Magneto-emulsion vectorisee
FR3061713B1 (fr) * 2017-01-11 2020-02-14 Universite D'orleans Complexes de lanthanides a base de derives d'acide triethylenetetramine-n,n,n',n'',n''',n'''-hexaacetique
WO2020007822A1 (fr) 2018-07-02 2020-01-09 Conservatoire National Des Arts Et Metiers (Cnam) Nanoparticules de bismuth métallique (0), procédé de fabrication et utilisations de celles-ci

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551480C3 (de) 1975-11-15 1982-04-22 Hoechst Ag, 6000 Frankfurt Technetium-99m-markiertes Nierendiagnostikum und Verfahren zu seiner Herstellung
US4339426A (en) 1980-03-18 1982-07-13 Regents Of The University Of California Bleomycin analog
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
DE3404443A1 (de) * 1984-02-08 1985-08-08 Hartmut Prof. Dr. 1000 Berlin Köpf Metallicenium-salze und deren verwendung als cytostatica bei der krebsbekaempfung
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
EP0188256B1 (fr) * 1985-01-14 1991-08-21 NeoRx Protéines marquées par un radionuclide d'un métal pour diagnostic et thérapie
CA1282069C (fr) 1985-09-12 1991-03-26 Damon L. Meyer Complexes d'anticorps comprenant des agents therapeutiques ou de diagnostic modifies par des haptenes
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
EP0274343A1 (fr) * 1987-01-06 1988-07-13 IntraCel Corporation Système de réactifs avec une apo-enzyme, utilisé dans les analyses immunologiques et un procédé pour exécuter les essais immunologiques avec ce système
WO1989000062A1 (fr) 1987-07-07 1989-01-12 The Cancer Institute Board Radiotherapie
WO1989005853A1 (fr) 1987-12-15 1989-06-29 Synthetic Genetics Conjugue de chelate d'acide nucleique utilise comme agent therapeutique et de diagnostic
IL89222A (en) * 1988-02-09 1995-03-30 Mallinckrodt Inc Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins
CA1340527C (fr) * 1988-05-31 1999-05-04 Lidia Vallarino Complexes macrocycliques d'ions d'yttrium, de lanthanides et d'actinides, renfermant des fonctions de couplage peripherique
US5094950A (en) * 1988-06-07 1992-03-10 Nihon Medi-Physics Co., Ltd. Diethylenetriamine pentaacetic acid derivatives
HU219485B (hu) * 1988-06-24 2001-04-28 Dow Chemical Co. Eljárás 1,4,7,10-tetraaza-ciklododekán-származékok, ezek komplexei, valamint antitestekkel képzett konjugátumai, és ilyeneket tartalmazó gyógyszerkészítmények előállítására és a komplexeket, illetve konjugátumokat tartalmazó diagnosztikai készítmények
US5101041A (en) * 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
ES2070329T3 (es) 1989-07-20 1995-06-01 Sandoz Ltd Derivados de polipeptidos.
US5124471A (en) 1990-03-26 1992-06-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bifunctional dtpa-type ligand
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
US5310539A (en) * 1991-04-15 1994-05-10 Board Of Regents, The University Of Texas System Melanin-based agents for image enhancement
JPH0616561A (ja) * 1991-07-09 1994-01-25 Tsumura & Co 抗レトロウイルス剤
EP0594749A1 (fr) * 1991-07-15 1994-05-04 Repligen Corporation Compositions pf4 et procedes d'utilisation desdites compositions
CA2113578A1 (fr) * 1991-07-19 1993-02-04 Ann E. Huang Composes trifonctionnels specifiques de cellules multiresistantes
DE4134158C2 (de) * 1991-10-11 1997-02-13 Max Delbrueck Centrum Verwendung von Carboplatin in lyotrophen Mesophasen zur Überwindung einer durch Zytostatika ausgelösten Leukopenie
US5326778A (en) * 1992-03-03 1994-07-05 Research Corporation Technologies, Inc. Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
EP0630407B1 (fr) 1992-03-11 2000-08-02 PRENDERGAST, Kenneth, Francis Peptides de fusion anti-viraux
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
JP3358141B2 (ja) * 1992-05-07 2002-12-16 アメルシャム ヘルス アクスイェ セルスカプ 錯化剤と金属放射性核種イオンとの錯体及びそれを含む診断用組成物
GB2268494B (en) * 1992-07-08 1996-08-21 Kenneth Francis Prendergast Imaging compositions
JPH08502300A (ja) * 1992-10-14 1996-03-12 スターリング ウィンスロップ アイエヌシー． 治療および診断像形成組成物および方法
WO1995019791A1 (fr) * 1994-01-24 1995-07-27 Neorx Corporation Annexines marquees isotopiquement
CA2189051C (fr) 1994-04-29 2008-06-17 M. Jules Mattes Composition destinee a l'apport de radio-isotopes toxiques au noyau de la cellule, et son utilisation
DE4435087A1 (de) 1994-09-30 1996-04-04 Deutsches Krebsforsch Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen

Similar Documents

Publication Publication Date Title
WO1996025956B1 (fr) Conjugue pour le dosage individuel de medicaments
DE69123235T2 (de) Biotinylierte monoklonale Antikörper, Avidin und Biotin für die Diagnose und Therapie
Spatz The retino-geniculo-cortical pathway in Callithrix. II. The geniculo-cortical projection
DE69624116T3 (de) Verfahren zur behandlung von allergischem asthma
DE69518839T2 (de) Mehrschichtige pharmazeutische dosierungsform mit kontrollierter freigabe
DE69131881T2 (de) 99mTc MARKIERTE LIPOSOMEN
DE69212630T2 (de) Bilderzeugungsmittel für Diagnose
EP0709088B1 (fr) Système d'administration transdermique de naloxone
DE2920770A1 (de) Reduktionsmittel fuer technetium-99m und reduktionsverfahren unter bildung von mit technetium markierten stoffen
DE3939706C1 (fr)
DE3538619C2 (de) Pharmazeutische Verwendung eines Isomeren des 4-Hydroxyprolin
Kornfeld et al. Metabolism of 14C‐labeled pyridostigmine in myasthenia gravis: Evidence for multiple metabolites
EP0810883A2 (fr) Conjugue pour le dosage individuel de medicaments
DE60117122T2 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
Egbring et al. Diagnostische und therapeutische Probleme bei congenitaler Afibrinogenämie
DE69815724T2 (de) Transparente körperpflegemittel
Carme et al. Current practices for the prevention and treatment of malaria in children and in pregnant women in the Brazzaville region (Congo)
EP1276770B1 (fr) Proteines presentant une forte immunoreactivite et leur procede de production
DE3880691T2 (de) Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.
DD297064A5 (de) Reagens zum nachweis der fibrinolytischen aktivitaet
DE3250068C2 (fr)
Karlik Common pharmaceuticals alter tissue proton NMR relaxation properties
DE60004519T2 (de) Molekuläre komplexe mit hoher affinität für monozyt-derivierte zellen und deren therapeutische verwendung
EP0420880B1 (fr) Procede de representation en images de tumeurs au moyen d'anticorps monoclonaux
Brooks et al. Three-compartment modeling of C-11 N-methyl spiperone kinetics in the human brain